These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 38002259)

  • 1. Total 25-Hydroxyvitamin D Is an Independent Marker of Left Ventricular Ejection Fraction in Heart Failure with Reduced and Mildly Reduced Ejection Fraction.
    Szabo TM; Nagy EE; Kirchmaier Á; Heidenhoffer E; Gábor-Kelemen HL; Frăsineanu M; Cseke J; Germán-Salló M; Frigy A
    Biomolecules; 2023 Oct; 13(11):. PubMed ID: 38002259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction.
    Nolte K; Herrmann-Lingen C; Platschek L; Holzendorf V; Pilz S; Tomaschitz A; Düngen HD; Angermann CE; Hasenfuß G; Pieske B; Wachter R; Edelmann F
    ESC Heart Fail; 2019 Apr; 6(2):262-270. PubMed ID: 30784226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors and prognostic implications of left ventricular ejection fraction trajectory improvement in the spectrum of heart failure with reduced and mildly reduced ejection fraction.
    Si J; Ding Z; Hu Y; Zhang X; Zhang Y; Cao H; Liu Y
    J Cardiol; 2024 Apr; 83(4):250-257. PubMed ID: 37802201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High serum fibroblast growth factor 21 levels were related to the prognosis and ventricular remodeling of heart failure patients with mildly reduced and reduced ejection fraction.
    Fan L; Gu L; Yao Y; Ma G
    Perfusion; 2024 Mar; 39(2):285-293. PubMed ID: 36321746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain).
    Farré N; Lupon J; Roig E; Gonzalez-Costello J; Vila J; Perez S; de Antonio M; Solé-González E; Sánchez-Enrique C; Moliner P; Ruiz S; Enjuanes C; Mirabet S; Bayés-Genís A; Comin-Colet J;
    BMJ Open; 2017 Dec; 7(12):e018719. PubMed ID: 29273666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular function and coronary microcirculation in patients with mild reduced ejection fraction after STEMI.
    Ma Y; Wang L; Jin W; Zhu T; Liu J; Zhao H; Wang J; Lu M; Cao C; Jiang B
    BMC Cardiovasc Disord; 2022 Sep; 22(1):423. PubMed ID: 36154928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China].
    Wang H; Li YY; Chai K; Zhang W; Li XL; Dong YG; Zhou JM; Huo Y; Yang JF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):865-874. PubMed ID: 31744275
    [No Abstract]   [Full Text] [Related]  

  • 8. Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory risk.
    Miller RJH; Nabipoor M; Youngson E; Kotrri G; Fine NM; Howlett JG; Paterson ID; Ezekowitz J; McAlister FA
    ESC Heart Fail; 2022 Jun; 9(3):1564-1573. PubMed ID: 35261203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of sacubitril/valsartan in the treatment of chronic heart failure with reduced ejection fraction in hypertensive patients with comorbidities: From clinical trials to real-world settings.
    Mazza A; Townsend DM; Torin G; Schiavon L; Camerotto A; Rigatelli G; Cuppini S; Minuz P; Rubello D
    Biomed Pharmacother; 2020 Oct; 130():110596. PubMed ID: 34321170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left atrial volume and left ventricular mass indices in heart failure with preserved and reduced ejection fraction.
    Gehlken C; Screever EM; Suthahar N; van der Meer P; Westenbrink BD; Coster JE; Van Veldhuisen DJ; de Boer RA; Meijers WC
    ESC Heart Fail; 2021 Aug; 8(4):2458-2466. PubMed ID: 34085774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline characteristics of 547 new onset heart failure patients in the PREFERS heart failure study.
    Linde C; Ekström M; Eriksson MJ; Maret E; Wallén H; Lyngå P; Wedén U; Cabrera C; Löfström U; Stenudd J; Lund LH; Persson B; Persson H; Hage C;
    ESC Heart Fail; 2022 Aug; 9(4):2125-2138. PubMed ID: 35403374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comorbidities, Fragility, and Quality of Life in Heart Failure Patients With Midrange Ejection Fraction.
    Gastelurrutia P; Lupón J; Moliner P; Yang X; Cediel G; de Antonio M; Domingo M; Altimir S; González B; Rodríguez M; Rivas C; Díaz V; Fung E; Zamora E; Santesmases J; Núñez J; Woo J; Bayes-Genis A
    Mayo Clin Proc Innov Qual Outcomes; 2018 Jun; 2(2):176-185. PubMed ID: 30225447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Depression and Anxiety with Cardiac Structural and Functional Characteristics in Heart Failure with Reduced and Mildly Reduced Ejection Fraction.
    Szabo TM; Nagy EE; Kirchmaier Á; Heidenhoffer E; Gábor-Kelemen HL; Frăsineanu M; Frigy A
    Clin Pract; 2023 Mar; 13(2):398-409. PubMed ID: 36961061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.
    Farmakis D; Simitsis P; Bistola V; Triposkiadis F; Ikonomidis I; Katsanos S; Bakosis G; Hatziagelaki E; Lekakis J; Mebazaa A; Parissis J
    Clin Res Cardiol; 2017 May; 106(5):359-368. PubMed ID: 27999929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Vitamin D on Cardiac Function in Patients With Chronic HF: The VINDICATE Study.
    Witte KK; Byrom R; Gierula J; Paton MF; Jamil HA; Lowry JE; Gillott RG; Barnes SA; Chumun H; Kearney LC; Greenwood JP; Plein S; Law GR; Pavitt S; Barth JH; Cubbon RM; Kearney MT
    J Am Coll Cardiol; 2016 Jun; 67(22):2593-603. PubMed ID: 27058906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF).
    Rickenbacher P; Kaufmann BA; Maeder MT; Bernheim A; Goetschalckx K; Pfister O; Pfisterer M; Brunner-La Rocca HP;
    Eur J Heart Fail; 2017 Dec; 19(12):1586-1596. PubMed ID: 28295985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Implications of Functional Mitral Regurgitation Severity in Patients with Heart Failure with Reduced Ejection Fraction (HFrEF).
    Naser N
    Med Arch; 2022 Feb; 76(1):17-22. PubMed ID: 35422569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post-hoc analysis of the ATHENA trial.
    Vaduganathan M; Piccini JP; Camm AJ; Crijns HJGM; Anker SD; Butler J; Stewart J; Braceras R; Albuquerque APA; Wieloch M; Hohnloser SH
    Eur J Heart Fail; 2022 Jun; 24(6):1094-1101. PubMed ID: 35293087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empagliflozin: A Review in Symptomatic Chronic Heart Failure.
    Frampton JE
    Drugs; 2022 Nov; 82(16):1591-1602. PubMed ID: 36374374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic value of the electrocardiogram in stable outpatients with type 2 diabetes.
    Gregers MCT; Schou M; Jensen MT; Jensen J; Petrie MC; Vilsbøll T; Goetze JP; Rossing P; Jørgensen PG
    Scand Cardiovasc J; 2022 Dec; 56(1):256-263. PubMed ID: 35811473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.